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Abstract 
Objective: This research study aimed to explore pharmaceutical waste prevention and 
disposal practices in nurse populations. 
Methods: A descriptive, cross-sectional survey was employed through the Qualtrics survey 
system. The survey questions were designed to probe knowledge, behavior, and attitudes 
of nurses towards pharmaceutical waste. Participants included intensive care unit nurses 
and perioperative nurses in the Yale New Haven Health System. 
Results: A total of 104 surveys were collected. Nurses were asked about the importance of 
proper waste disposal, and 95.2% of nurses (N=99/104)  believed that appropriate waste 
disposal is important to “protect the environment health.” The survey also asked about the 
top reason that contributes to improper waste disposal practices, and 56.7% of nurses 
(N=59/104 believed that the “lack of knowledge about waste segregation” is the top reason 
for improper disposal practices. Nurses were also asked about reasons that contributed to 
avoidable waste, and 37.5% of nurses (N=39/104 indicated that “the order for medication 
that is less than the available package size” is the top reason contributing to avoidable 
waste. 
Conclusion: The survey uncovered a considerable gap in nurses’ knowledge of 
pharmaceutical waste management and shed light on specific behaviors that can potentially 
lead to improper disposal practices.  Findings of this research study suggest that the 
implementation of pharmaceutical education and training may result in waste prevention 
which in turn could improve waste impacts on the environment and public health.  
Keywords: pharmaceutical waste disposal; waste prevention, nursing education; 
environmental contamination, YSPH Environmental Health Sciences 
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Chapter 1: Introduction 
Purpose of Study 
According to the United States Environmental Protection Agency, hospitals 
generate up to 15,000 tons of pharmaceutical waste per year (EPA, 2015).Health care 
facilities must ensure that pharmaceuticals are disposed of correctly to stay within 
compliance of regulatory agencies. There are many challenges to achieving proper 
waste disposal, due to complex federal and state regulations, intended to protect 
patients, occupational groups, and the environment. Gaps in drug disposal mandates 
exist, and regulations do not explicitly cover certain types of drug waste. In response 
to the differences at the regulatory level, hospitals and institutions have developed 
individual waste systems to handle healthcare waste that is not addressed by 
regulations. The complex regulatory milieu is very confusing, therefore, and improper 
waste management behaviors are common.  At the occupational level, additional 
challenges include variable adherence practices among individuals for proper waste 
management, creating further confusion between staff.  
Regulatory agencies play a significant role in the development of 
protocols for drug waste management. More specifically, drug disposal 
practices should follow specific protocols such as those in place for controlled 
substances from the Drug Enforcement Administration, Resource Conservation 
and Recovery Act, and the Environmental Protection Agency. However, many 
pharmaceuticals not within such protocols are state regulated, which may 
contribute to gaps in clinical waste management. To streamline the waste 
management of drugs, hospitals can implement local procedures to protect the 
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environment. Furthermore, to be in compliance, and meet production 
pressures, nurses may be engaging in practices that result in unnecessary 
disposal of an unused drug due to regulatory complexity, production pressures, 
and/or lack of awareness for public health impact. One goal of this project is to 
encourage pharmaceutical management policies and procedures that promote 
waste prevention, in addition to proper waste disposal methods.   
This investigation explores nurse attitudes and behaviors about pharmaceutical 
drug waste at Yale New Haven Hospital (YNHH). Moreover, the study explores 
attitudes toward pharmaceutical management policies and procedures to understand 
better how to optimize drug stewardship at the health professional level. Its goals are 
to understand drug waste from the occupational perspective of pharmaceutical waste 
administration, focus on quality improvement of waste management, and explore 
methods for waste prevention. The results of this thesis may inform policy or practice 
reform to allow for more streamlined drug waste methodologies and prevention 
techniques for medical personnel, administrators, and regulators (OSHA Drug Manual, 
2018).  
Significance of this Project 
The United States healthcare sector is accountable for ten percent of the 
nation's greenhouse gases.  Hospitals produce an appreciable amount of pollution: 
anesthetic gases that tear through the ozone layer, pharmaceutical drug waste that 
affects water sanitation and social health and foods that are unsustainable for the 
environment. For this reason, these institutions are interested in making systemic 
changes. The significance of waste prevention offers the opportunity to cut costs and 
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cut impacts on the environment. Additionally, due to the large influx of pharmaceutical 
waste, the prevention of pharmaceutical disposal could be another The prevention of 
pharmaceutical waste is an encouraged and necessary action for institutions 
developing waste due to the multiple methods of disposal and treatment which may 
lead to increased adverse effects on health and environmental issues. It is imperative 
to decrease pharmaceutical waste because of the impacts on costs, more importantly, 
impacts on environmental and public health. (EPA, 2014). 
Currently, the FDA approves an average of thirty new drugs each year. The 
United States alone invests about eighty-six billion dollars into research and 
development. With the high demands of healthcare structure and innovation, the global 
industry expects at least one thousand new drugs on the market by 2050 (Kepplinger, 
2015). Pharmaceuticals enter the environment via consumers, pharmacological trials, 
hospitals, and agriculture/aquaculture fields. More explicitly, the increase in 
pharmaceutical drugs in hospital and clinical settings is concerning for the environment 
and public health due to the increase in the disposal. 
Chapter 2: Background of Study 
 Pharmaceutical Waste Management 
Because of the different classes of drugs that are opened and prepared, 
different types of disposal treatment methods are required for safe management. 
Pharmaceutical waste consists of any pharmaceutical product (drug and delivery 
systems including needles, syringes, tubing, bags, etc.) designated for discard. The 
types of disposal classes include controlled substances, hazardous waste, non-
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hazardous waste, and chemotherapy waste. (See Figure 1). The Department of 
Energy and EPA define hazardous waste as: ignitable, corrosive, reactive or toxic. 
Among these are antibacterials, antibiotics, endocrine disruptors, plasticizers, steroids, 
and other anti-metabolites.  Hazardous waste includes P-Listed (acutely toxic 
chemicals), U listed (toxic chemicals), and D- Listed (characteristic hazardous waste). 
(Figure 2). (Paone, Vogenberg, & Caporello, 1996).  
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Regulatory Agency Role in Pharmaceutical Waste 
Pharmaceutical waste cannot be disposed of like general waste and requires 
handling that adheres to regulatory agency protocols. In 1976, the Resource 
Conservation and Recovery Act (RCRA) was established which governed the 
management of solid and hazardous waste generated within the United States. 
Management of pharmaceutical waste further differs on a state by state basis (Doerr & 
Haight, 2006). Also, the Drug Enforcement Administration (DEA) oversees waste 
management of controlled substances, to further ensure prevention of “diversion” for 
resale/reuse. Finally, many pharmaceutical products are not covered by these 
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guidelines, and are state and/or facility-regulated (Buszska et al., 2009). 
The complexity and lack of consistency in protocols for pharmaceuticals lead to 
confusion and gaps in knowledge about proper waste disposal. Table 1 shows the 
breakdown of key stakeholders involved in pharmaceutical waste management. There 
are disparate regulations across the United States. One example is that the current 
Connecticut Pharmaceutical Waste Stream allows for an intravenous solution such as 
saline to be disposed of through the sewer system. This type of waste management is 
through the state Publicly Owned Treatment Works (POTW), and institutions need a 
discharge permit to allow for this type of disposal. However, in Wisconsin, it is not 
permitted to dispose of saline through sewer systems and fines could result for 
institutions caught disposing of such materials through this method (UWG, 2015). 
Improvements in the understanding of procedures and policies are critical. (Bound, 
Kitsou, & Voulvoulis, 2006). 
Policies Requiring Specific Disposal Pathways 
Controlled substances and Drain Disposals 
Controlled Substances are drugs or chemicals whose manufacture, possession, 
or use is regulated by the Drug Enforcement Administration (DEA. The DEA proposed 
the Controlled Substance Act (CSA) which requires that controlled substances must not 
be in reach for reclamation, and two professionals must document destruction. For 
controlled substances, drain disposal is the most common method for removal to ensure 
the drugs are unrecoverable. The DEA mentions the following schedules for controlled 
substances: 
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1. “Schedule I includes drugs that have no accepted medical use, such as heroin.” 
2. “Schedule II drugs are used medically but have high abuse potential, such as 
morphine, and their purchase, storage, and use requirements are very strictly 
monitored.” 
3. “Schedules III through V are drugs with decreasing abuse potential, all the way 
from sedatives to cough suppressants, such as codeine.”  (DEA, 2014) 
Under certain circumstances, there is an exclusion that allows drain disposal of 
P-listed wastes. This depends on the size of the waste generator and how the waste 
enters the sewage system (HERC, 2016). This also includes certification of a program 
in place to reduce volume and toxicity of hazardous wastes generated (DEA, 2014) the 
drain disposal method is causing more complications for publicly owned treatment plans 
and regulatory agencies like the USEPA are discouraging this method (Rannazzasis, 
2014).    
Regulatory agency mandates for treatment of unused pharmaceuticals are 
intended to protect the public from inadvertent poisoning. In some cases, flushing 
unused pharmaceuticals down the toilet or throwing them down the drain was 
considered the safest and simplest way of disposal. However, the consequences on the 
environment and its potential impacts on public health are revealing environmental 
concerns such as polluted water streams and impacted ecosystems. 
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EPA establishes cost- saving, streamlined standards for handling hazardous waste pharmaceuticals to fit the 
operations of the healthcare sector better while maintaining protection of human health and the environment. 
while maintaining protection of human health and the environment. Enforces Clean Air Act, Clean Water Act, 
Resource Conservation & Recovery Act (RCRA), and Toxic Substances Control Act (TSCA) 
Department of Transportation 
(DOT)  DOT regulates personnel training, packaging, and transporting requirements related to hazardous materials; 
these regulations are also enforced by the Federal Aviation Administration with regard to shipping specimens.(49 




DEA Enforces Controlled Substances Act (CSA) which provides a mechanism for substances to be controlled 
(added to or transferred between schedules) or decontrolled (removed from control). Among other aspects 
relative to controlled substances, this act regulates their disposal (Disposal of Controlled Substances) 
Occupational Safety & Health 
Administration  
(OSHA) 
OSHA Regulates several aspects of medical waste, including management of sharps, requirements for containers 
that hold or store medical waste, labeling of medical waste bags/containers, and employee training. These 
standards are designed to protect healthcare workers from the risk of exposure to blood-borne pathogens. 
However, they also help to systematically manage wastes, which benefit the public and the environment. 
State Environmental Protection 
Agency 
Nearly all 50 states have enacted medical waste regulations to some extent. Most states have regulations 
covering packaging, storage, and transportation of medical waste. Some states require health care facilities to 
register and/or obtain a permit. State rules may also cover the development of contingency plans, on-site 
treatment, training, waste tracking, recordkeeping, and reporting. 
Local Publicly Owned Water 
Treatment Works 
(POTW) 
POTW manage the materials being flushed or poured down the drain. There are restrictions on types of 
chemicals (including pharmaceuticals), blood and other materials. POTW is managed locally, though, they are 
bound by Federal EPA standards under Water Division and often further regulated by State regulatory agency  
Source: Healthcare Environment Resource Center 
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Pharmaceutical Processing Pathways 
Disposal and treatment is a primary source of environmental contamination by 
pharmaceuticals (Bottani et al., 2010). Once pharmaceuticals enter into the disposal 
stream, hospital environmental safety officers must ensure the proper management. 
All approaches must consider the environmental, financial, and technical application of 
treatment and disposal technologies (WHO, 1999).  
All waste disposal and treatment methods have impacts on health and 
environment (EPA, 2014). Improper disposal of pharmaceuticals may be hazardous if 
it leads to contamination of water supplies used by nearby communities (WHO, 1999). 
Additionally, burning pharmaceutical waste at low temperatures or in open containers 
releases toxic pollutants into the air (EPA, 2014). The US EPA mentioned that medical 
waste incineration is the largest source of dioxin air pollution (US EPA, 1997). 
Pharmacaeutical waste dumped in could create the possibility of leachate entering an 
aquifer, surface water or drinking water system. Treatment and disposal processes 
must consider the impacts on the environment and public health. 
Furthermore, treatment and disposal methods can create significant costs on 
waste compliance fees (EPA, 2014).  In most cases, waste companies charge for 
biomedical waste by the pound, and as mentioned, hospitals can create up to 15,000 
tons per year; therefore, disposal fees can amount to hundreds of thousands of dollars 
each year. Waste prevention is not only significant for decreased sources of 
contamination, but it also proves to be another important reason for saving on costs 
(EPA, 2014).  . 
There are five waste different treatment methods, depending on the type of 
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drug classification as shown in Figure 3. These include incineration, autoclaving, 
microwave, chemical treatment, and landfill. The ideal aim for better waste stream 
systems and prevention methods should adhere to the triple bottom line: reduce costs, 
protect ecosystems, and prevent adverse health outcomes from environmental 
impacts.  
 
Exploring Pharmaceutical Waste Prevention and Disposal Practices in Nurse Populations 19 
 
Table 2: Pharmaceutical Waste Treatment and Disposal (Stericycle 2018 and EPA 2017): 
 
Method Description Environmental/Health 
Impact 
Capital Costs Handling for Each Type of Drug 
Incineration The burning of waste at 
high temperatures (800-
900 °C) under oxygen-
starved conditions. 
   
Residual ash is land-filled, 
and can cause soil, air and 
water contamination.  
 
Water emissions occur 
when wet scrubbers are 
employed to remove 
particulates  
 
Burning of fossil fuels can 
result in air pollution (e.g., 
particulate matter 2.5) 
  
$2000-$100,000 
   
   
   
  
    
   
Bulk and Trace Chemotherapy 
Pharmaceuticals 
    
Autoclaving  
   
  
The steam heat of at 
least 121°C, combined 
with pressure are used 
to destabilize drugs and 
decontaminate 
associated sharps (e.g., 
needles). 
 
Heat transfer penetrates 
the waste load. 
Shredding will increase 
the exposure of waste to 
treatment, render sharps 
After autoclaving, waste 
goes to landfill. Waste can 
result in soil and land 
contamination through 
leaching of residual 
compounds. 
 
Contamination of water can 
occur from effluent.  
$36,000– $889,000  
   
   
Red Bag (Non-pathology) 
Red Sharps (Needle Bag) 
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“unrecoverable,” as well 
as reduce waste volume.  
***Byproduct can be 
landfilled 
  
Microwave This process uses 
radiant energy to heat 
moisture within the 
waste and/or heat water 
that is added to the 
waste. Microwaving units 
kill infectious agents and 
drugs through heat and 
pressure, not as a result 
of exposure to the 
microwaves.  
   
After microwaving, waste 
goes to landfill. Waste can 
result in soil and land 
contamination through 





$600,000 Bulk and Trace Chemotherapy 
Pharmaceuticals 
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Chemical Treatment Chemicals are 
introduced into a 
sterilization chamber. 
With proper exposure 
conditions, waste is 
sterilized before going to 
landfill 
Sewage treatment 
processes can be 
negatively impacted by 
residual chemical 
compounds in waste water 
effluent.  
.      
With some chemical 
systems there is potential 
soil contamination in 
landfills.   
   
30,000-450,000 Bulk and Trace Chemotherapy 
Pharmaceuticals 
Landfill Landfills place waste 
directly into a land 
disposal site without 
prior treatment or 







3) Highly engineered 
sanitary landfill 
 
“One half of available 
carbon is converted to 
methane during 
degradation. Methane is 25 
times more destructive to 
the ozone layer than carbon 
dioxide.” 
 
Landfill must be monitored 
to prevent contamination of 
ground water. 
 
Must remove materials 
containing lead and 
mercury from landfills to 
decrease leachate in soil 
and water 
--------- Red Bag (Non-pathology) 
Red Sharps (Needle Bag) 
Municipal Trash 
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Impacts on Public Health 
 Pharmaceuticals are developed to intentionally resist biodegradation, which can 
impact public health. One study conducted by the U.S. Geological Survey found 
prescription and nonprescription drugs in about 80% of 139 streams in the United 
States (USGS, 2014). Moreover, the National Resources Defense Council reported in 
2008 that pharmaceuticals are present in public drinking water supplies serving over 
forty million Americans across the United States (NRDC, 2010). In a current research 
study from the US Geological Survey, the national impact report of water supplies 
noted that hospitals are the critical drivers and sources of contamination by hazardous 
drugs. The wide range of pharmaceuticals detected in waste waters, surface water, 
groundwater, and drinking water creates a public health issue due to the potential for 
transfer to a human directly and indirectly (USGS, 2014). These impacts show the 
necessity for pharmaceutical policies and procedures that better adhere to drug 
stewardship in the form of waste prevention and proper disposal.  
Impacts of Pharmaceuticals in the Environment 
Due to the pervasiveness of pharmaceuticals in the environment and concern 
for environmental exposures, drug stewardship is a significant topic for hospitals, which 
are primary drivers of drug utilization and waste (Zuccato et al., 2006). 
Pharmaceuticals differ from other environmental pollutants in that they are developed 
to be biologically active and these chemicals will interact with cells following the 
properties of absorption, distribution, metabolism and excretion (Fatta-Kassinos et al., 
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2011). Though these properties are useful at the therapeutic level, they can have 
adverse effects in uncontrolled situations. Proper disposal and management, and 
waste prevention are necessary to minimize the detrimental impact of pharmaceutical 
waste on the environment.  
The negative impact of pharmaceuticals on the environment originates from the 
chemical effects of pharmaceuticals on the environment. Over six hundred different 
pharmaceutical agents and their metabolites are detected in seventy-one countries on 
all continents (Zhou et al., 2009). Ultimately these impacts can contribute to 
environmental problems, such as polluted water systems, contaminated soil, polluted 
ecosystems, and the emergence of resistant pathogenic bacteria (Donn et al., 2009). 
The number of pharmaceuticals detected water sources is rapidly increasing. 
Pharmaceutical drugs have negative impacts on aquatic species due to their 
susceptibility to toxicity effects. Aquatic species may serve as proxies for the human 
health impacts of environmental exposures. Detrimental effects on fish populations are 
consequences of pharmaceutical pollution and link to changes in energy metabolism, 
mitochondrial activity and reproductive failure. (Manuel et al., 2010). For example, one 
animal toxicology study demonstrated that the runoff of drugs like Prozac caused 
aquatic life such as crustaceans to undergo behavior changes such as abnormally 
swimming towards the light, leading to more significant exposure to phototoxic effects. 
(Rodriguez-Mozaz & Weinberg, 2010).The ubiquitous prevalence of pharmaceutical 
drugs poses long term and short term impacts. Long term impacts include skewed sex 
ratios among fish due to excessive hormone levels in water and short term impacts 
include contamination of water quality by eutrophication. Eutrophication is the impact 
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on the water by nutrient salts that causes changes in the ecosystem such as the 
depletion of fish species, deterioration of water quality and increased production of 
algae and plants. When medicines are prescribed in response to an acute or chronic 
illness, only a portion may be metabolized, and the non-metabolized portion (Active 
Pharmaceutical Ingredients (API). Both metabolites and APIs can enter the 
environment through wastewater effluent and landfill soil routes. While doses may be 
“sub-therapeutic,” there is growing concern about micro-exposures during key human 
development stages, as well as to unknown synergistic effects from multiple 
exposures.  
Limited Research on Chronic Health Exposure 
There is limited research on chronic health exposures and trace amounts of 
Active Pharmaceutical Ingredients in the environment. Many factors contribute to the 
limited research, such as the validity of using wastewater treatment plants as 
pharmaceutical waste detection sites, the presence of low levels/trace amounts in 
water, and the overall lack of evaluation of health risks (Cabello, 2006). 
Pharmaceuticals entering wastewater treatment plants are not transformed or 
removed, as such treatment technologies (e.g. reverse osmosis) are not implemented. 
Therefore, these chemicals are likely to be present in the effluents at high levels 
(Kemper, 2008). Wastewater treatment plants are identified as the main points of 
discharge of pharmaceuticals into surface waters and could assist with chronic health 
exposure research. However, the adequacy and efficiency of these plants as study 
sites have not been explored. (Chenxi, Spongberg, & Witter, 2008) 
Since pharmaceuticals are now routinely found in the environment at low or 
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trace levels, there is a need for further exploration on lasting impacts. For example, 
one study monitoring drinking water found the presence of sixteen pharmaceutical 
compounds (Nassiri & Abdollahi 2017). The human health risk assessments showed 
low levels of risk; however, the chronic effects are not clear due to the limited 
exposure time. Another study exploring pharmaceutical waste in tap water in China 
found seventeen active drugs. However, thirteen of the drugs were deemed to be low 
risk, and four were found to have at least one life-stage risk, which could be 
threatening to infant and child life stages. The researchers proposed the need for 
more research and proposed an indicator-based monitoring framework to better 
identify the source (Leung et al., 2013). Though several studies are concluding low 
health risks, there is a necessity for chronic exposure research and analysis of low-
dose of pharmaceutical waste at a high interval (pseudo persistence) (Donn et al., 
2008). 
The amount of environmental data for pharmaceuticals is not sufficient to make 
definitive associations. Many pharmaceutical studies focus on “single grab samples” 
which do not adequately capture variation and may not represent actual 
concentrations (Leung et al., 2013). Instead, representative sampling including spatial 
variability concerning land and drug use and temporal variability should be explored. 
Additionally, pharmaceuticals represent several hundred chemicals which could also 
be a factor in limited chronic exposure, and this is a challenge for researchers to study 
source characterization and exposure assessment. Though most pharmaceutical 
companies offer physicochemical data on specific pharmaceuticals, exposure 
assessment is still a challenge due to the toxicology of mixtures and complicating 
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factors such as unknown soil-water partition, biodegradation rates and distribution 
coefficients (Rodriguez & Weinberg, 2010).There is a need for longer-term research 
on the chronic exposure of drug waste, and it is an evolving concern due to the lack of 
long-term exploration for these compounds. The impact of pharmaceutical waste on 
health systems is an area in epidemiology and toxicology where research is critical 
(Leung et al., 2013). 
Intersection of Occupational Health and Pharmaceutical Waste Management 
Nurses are vital contributors to the generation of, and disposal of pharmaceutical 
waste. Nurses play one of the most active roles in pharmaceutical management given 
their profession to administer and dispose of patient medicines. Additionally, nurses 
work across patient and community settings where medications are stored, monitored 
and eliminated (Practice Green Health, 2016). However, universal management 
guidelines may not always be available or taught at nursing school. Often, nurses may 
engage in practices that result in unnecessary drug waste generation as well as 
improper disposal due to regulatory complexity, production pressures, and ignorance of 
public health impacts of their behaviors. Nurses generally do not receive training on 
hazardous waste management during their studies and may not be familiar with active 
ingredients. To combat these gaps in knowledge, the American Nurses Association 
(ANA) adopted a policy to describe nurses’ role in pharmaceutical waste generation and 
disposal (Stanton, 2011). The ANA policy also adds education and supervision to the 
framework to promote proper use and disposal in the community (Murphy et al., 2013).  
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Unused and Unavoidable Pharmaceutical Waste 
 The phrase “drug waste” may be confusing, as it refers to the act of disposing 
of unused drugs, the substance itself being disposed of, and furthermore whether the 
unused drug is avoidable. In some cases, unused drug waste is unavoidable; for 
example, if a patient gets better and no longer needs infusions. Unavoidable 
pharmaceutical waste may be generated through different processes in a healthcare 
facility including, but not limited to, the following: the patient's medical condition has 
been resolved, the medication causes an adverse effect and must be discontinued, 
physicians switch medicine due to new information, or the patient dies (Walters, 
1992).  
Avoidable Pharmaceutical Waste 
Often, the generation of an unused drug is avoidable. Protocols and behaviors 
contribute to significant drug waste due to factors both intrinsic and extrinsic to 
hospitals or clinics. This is inclusive of a complex federal and state regulatory milieu 
that mandates drug packaging, preparation, administration, expiration, and disposal 
procedures intended to protect patients, occupational, and environmental safety. 
Additionally, regulatory gaps filled by local policies to achieve regulatory compliance 
and occupational work flow including production pressures that drive expedient 
compliance (HERC, 2016). Figure 4 shows the most common situations that create 
avoidable waste including error in provider orders, changes in provider orders, 
expiration of an open drug, production pressures leading to changing infusions 
prematurely, and the order for medication is less than the available package size. 




Behaviors and Policies Contributing to Hospital Drug Waste and Pathways  
Avoidable waste is a large component of pharmaceutical waste; however, there 
are many behaviors and policies not included. This section focuses on avoidable waste 
by highlighting behaviors such as medication error and specific policies that call for 
wasting pharmaceuticals (American Society of Consultant Pharmacists, 2014). The 
exploration of behavior and system can offer insight into where and when hospital drugs 
are spent and how certain drugs must be wasted according to protocol. 
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Behaviors and Procedures Impacting Hospital Drug Waste 
Dispensing Error 
Dispensing errors can occur when pharmaceuticals are administered and 
delivered by the pharmacy or medicines are supplied by drug dispensing machines (like 
a Pyxis machine), and are inaccurate (Uribe et al., 2002). For example, some of these 
errors include labeling errors, the wrong quantity of a drug, wrong dose, duplication, 
wrong drug, wrong dosage form, and wrong patient. The impacts of dispensing error are 
to increase pharmaceutical waste in the department and according to Joint Commission 
on Accreditation of Healthcare Organization standards, once the pharmaceutical is 
dispensed “to the floor” the medicine can no longer be sent back to the pharmacy if it is 
incorrect (HCPR, 2003), thus resulting in an automatic waste (Hughes & Blegen, 2008). 
Standardized Timing  
Standardized timing of drugs may not fall conveniently within nursing shifts, or 
dynamic patient care duties. Nurses may change infusions or medications prematurely, 
to adhere to “per shift” drug/tubing change infection prevention policies. There may be 
pressure to change medications earlier to accommodate breaks and expedite shift 
change to stay within compliance. The timing of pharmaceuticals is a regulated process; 
however, organizational issues such as the absence of labeling and shift schedules may 
result in premature drug delivery systems replacements resulting in avoidable waste 
(Fogarty & McKeon, 2006). (Olsen et al., 2007).  
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Work Environment Factors 
Not all healthcare systems develop consistent disposal and pharmaceutical 
management systems, and in some situations, nurses may be overworked with higher 
patient loads. To elaborate, some of these pressures within organizations include 
demanding turnaround time for patient care (early discharge, higher patient loads). 
These may be examples of factors that are determined at the administration level. 
Medication errors are associated with heavier workloads (Fogarty & McKeon, 2006). In 
some situations, there may be a nurse shortage which ultimately increases work 
pressure and the number of patients per nurse. The nursing work environment may 
increase medication errors due to the need for urgency in many situations, which can 
create more pharmaceutical waste (Rogers, Hwang, & Scott, 2004). 
Standardized Concentrations  
Standardization of medications is intended to avoid error in calculations, reduce 
waste, streamline inventory, and facilitate the use of Intravenous premixed solutions. 
When more than one concentration is needed for medications, the standardization 
typically requires another request for another drug to maintain safe handling (Beyeya, 
Hicks & Beker, 2003). This causes waste due to the need for a specific amount which 
may be less than or greater than the standardized concentration. Some hospitals take 
part in standardizing concentrations which are intended to avoid error and reduce 
waste; however, in some situations standardization does not allow individuals to choose 
the exact amount of medication resulting in more waste. 
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Studies in Hospital-based Settings 
Nine studies were identified that modeled pharmaceutical disposal in hospital-
based settings and the implications for waste (Tables 3-5). Overall, the literature 
explored measures that contribute to pharmaceutical waste volumes. The studies 
showed that the most commonly wasted medications included antibiotics for Intensive 
Care Units and propofol for Operating Rooms. All studies addressed the need for 
improved clinical design and avoidance of waste. In one specific study exploring ICU 
waste by Al-Dhawaille, researchers reported that 265 items of IV medication were 
collected during the study period and antibiotics preparations (77%) were the most 
unused and wasted. Medication discontinuation (60%) was the leading cause of such 
wastage (Al-Dhawaille, 2011). For the operating room, a common waste theme that 
emerged was the open availability and use of drugs (Abbasi & Gay, 2017). 
Most studies addressed the costs of preventable waste and the importance of 
exploring clinical redesign methodologies to decrease financial loss. One author stated 
that in the operating room specifically, anesthetic management of surgical cases can 
contribute substantially to total wastage costs; therefore careful use of these drugs was 
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Table 3 Matrix of Studies Exploring Unavoidable and Avoidable Waste 
First Author, 



















































al Study ICU Teaching Hospital IV 
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Chaudhary, 2012 India 
Observational 



















al Study ICU 
Children's 
Hospital IV 
Mankes,2012 USA Observational study 13 months 
International 
Anesthesia 
Society  Brief Report OR 
Academic 
Hospital Anesthetics 






al study OR 
Tertiary Care 
Hospital Anesthetics 
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Nava-Ocampo, 2004 Mexico 
Observational 











Table 4 Subgroup: Intensive Care Unit setting 
First Author, 
Publication Year 
Location Study Design 
Length of 
Study 








Abbassi, 2017 Tampa, Florida 
Observational 
Study 7 days Oral,IV 




phase 1 to phase 2 
($41 to $21 per 100 
patient days; p < 
.05) 
517 beds Total wasted CSPs decreased 
from 97 doses wasted in phase 1 
to 83 doses wasted in phase 2. 
These numbers represent 2.2% 
and 1.8%, respectively, of total 
CSPs prepared during each 
phase.  
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Almeida,2016 Sao Paulo, Brazil 
Observational 
Study 3 months IV 
------------ 356  units Most discarded pharmacological 
classes were: 22.7% 
antimicrobials, 14.8% 
electrolytes, 14.6% 





Study 1 month IV 
-------------- 430 units 265 items of IV medication were 
collected during the study period. 
Antibiotics preparations (77%) 
were the most unused and 
wasted. Medication 
discontinuation (60%) was the 
main cause for such wastage. 
L'Hommedieu, 2010 New York, USA 
Observational 
Study 30 days 
IV a weekly savings of 
$8,197 ($426,244 
annually),  
500 beds Wasted i.v. doses decreased 
from 1,339 (16.6% of the total 
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Design Length of Study 
Type of Pharmaceuticals  









nal Study 12 months 
Anesthetics 185,250 543 cases Preventable waste was generated 
most frequently for ephedrine 
(59.5% of cases), and 
succinylcholine (33.7%) 
Chaudhary, 2012 India 
Observatio
nal Study 12 months 
Anesthetics The cost of wasted 
drugs for the study 
duration was 46.57% 
$1604 of the total cost 




98 cases Maximal wastage was associated 
with adrenaline and lignocaine 
(100% and 93.63%, respectively). 
This is accounted for maximum 
wastage due to not being used after 
loading into a syringe. 
Mankes,2012  
Observatio
nal study 13 months 
Anesthetics ------------------ 8 operating rooms Propofol was the most widely 
dispensed and wasted drug at the 
facility. And accounted for 45% of 
the total drug waste by mL. 
Eliminating the 50 and 100 mL 
bottles of propofol reduced the 
facility's propofol waste from 29.2 
mL/day/bin to 2.8 mL/day/bin. 
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More, 2015 India 
Observatio
nal study 3 months 
Anesthetics The cost of wasted 
drugs for study 
duration was 29.82% 
$1027 of the total cost 
of drugs was loaded 
$3445. 
200 cases Thiopentone sodium was frequently 
used intravenous inducing 
anesthetic agent in 75% of patients. 
Amongst intravenous anesthetic 
agents maximum wastage was 
associated with propofol of about 
36.59% and in pre-an aesthetics, 
wastage was maximum for atropine 
79% followed by glycopyrrolate 
45.95%, pentazocine 45.95%.  
Nava-Ocampo, 2004 Mexico 
Observatio
nal Study 1 year Anesthetics 
The median 
undocumented cost 
was US$92.4 (95% CI 
$17.2–$216.6) per 100 
requested units. 
100 units Two specific drugs, rocuronium and 
nalbuphine, were found to have the 
highest waste 
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Chapter 3: Research Method  
A cross-sectional survey was conducted in February and March of 2019 at Yale 
New Haven Hospital, after approval by the Institutional Review Board at Yale University 
(#2000024892). The primary method of data collection was a self-administered survey. 
All surveys were entered anonymously, online, via Qualtrics survey Software (Qualtrics 
Laboratories, Inc., Provo, UT, USA).  Eligible participants were recruited via a secure, 
anonymous link to the survey instrument. Informed consent was obtained through the 
online survey that provided study information, the survey duration, participants’ rights, 
and contact information for a study representation about concerns or questions.  
The cross sectional survey consisted of a mix of quantitative and qualitative 
aspects of the survey, including open ended questions. The survey questions were 
designed to probe knowledge, behavior, and attitudes of nurses towards pharmaceutical 
waste. The survey also intended to understand what types of motivations drive the 
waste in the Intensive Care Unit (ICU) and Perioperative Units at Yale New Haven 
Hospital. The average time taken to complete and return the survey was four minutes. 
The final survey contained thirteen questions covering perception, knowledge, training, 
attitudes and two open-ended questions about commonly wasted pharmaceuticals and 
opportunities for waste disposal improvement. The survey questions were developed by 
one Anesthesiologist, one Occupational Health Director Physician, one Medical ICU 
nurse, and one Master of Public Health candidate.  
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The main outcome goals of the survey were nurses’ knowledge and attitudes 
towards pharmaceutical disposal practices, as well as waste prevention, and the factors 
that may have influenced them. The study focused on key independent variables: a) 
perception of knowledge about pharmaceutical disposal and prevention, b) attitudes 
towards improper waste segregation, c) behaviors in drug disposal, and d) opportunities 
for improvement. Data on predictors included gender, years of experience, and the 
highest degree earned. Results from the study also offered opportunities for 
improvements such as conditions that should be changed to increase compliance and 
most commonly wasted drugs.  
Participant Criteria 
To be eligible for the study, potential participants must be 18 years or older and a 
currently practicing nurse at the Yale New Haven Hospital’s Intensive Care Units or 
Perioperative Care Units. Nurses could hold any of the following degrees: Licensed 
Practical Nurse, Certified Prepared Registered Nurse, Advanced Prepared Registered 
Nurse, Bachelor of Science in Nursing, and Master of Science Nursing. Exclusion 
criteria included nursing students in the Yale New Haven Hospital Health system as well 
as participants who refused to give informed consent.  
Participant Recruitments 
Data collection took place at the Yale New Haven Hospital Health System 
(YNHH) Intensive Care Units (ICU) and Perioperative Care Units. Respondents were 
recruited based on flyer distribution via message boards, and via email distribution by 
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Nurse Patient Managers. Also,in-person recruitment was conducted in the Medical ICU 
at Saint Rafael Campus.  
Method of analysis 
Study data were recorded using Qualtrics and analyzed using the Statistical 
Package for Social Sciences (SPSS). Descriptive statistics of survey responses were 
calculated including frequency and percentages of data. Open ended questions were 
grouped and integrated with the descriptive quantitative results. To check the 
association between the predictors and the dependent variable, a Kruskal-Wallis test (a 
non-parametric version of ANOVA) was performed since the dependent variable was 
ordinal and then an ordinal logistic regression model was generated using predictors as 
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Survey 
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Chapter 4: Results 
Demographics 
Participants for the survey consisted of 122 Intensive Care Unit (ICU) (N=114) 
and Perioperative nurses (N=8) from the Yale New Haven Hospital Health campuses, 
York Street and Saint Raphael. Data excluded 16 participants because they had not 
completed the survey past the first 2 questions, and 2 participants were not ICU or 
Perioperative nurses. Thus the sample for the study was 104 survey respondents. 
The demographics of the participants are included in Table 6. 61.5% of nurses 
have a Bachelor’s in Nursing Science (N=64/104), and 44.2% worked as a nurse for 
one to five years (N=46/104). Additionally, 77.8% of nurses were female (N=81/104), 
and 83.7% of nurses (N=87/104) were ICU nurses from the Medical Intensive Care 
Units
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Knowledge about Pharmaceutical Waste (Questions 1-5) 
 The knowledge based portion of the survey begins with a question exploring the 
perception of nurses’ knowledge about pharmaceutical waste segregation. A statement 
was added prior to the question that reads: “There are many types of pharmaceutical 
waste streams in the hospital setting.  Waste segregation refers to placing a specific 
type of waste into the appropriate receptacle.” The participants were then asked about 
perception and waste segregation based on a Likert scale. The results showed that 
31.7% of nurses (N=33/104) either strongly agree or agree that they feel knowledgeable 
about which types of pharmaceutical waste go into each bin, while 32.7% of nurses 
(N=34/104) either disagree or slightly disagree with this statement.  
When nurses were tested on their knowledge about which types of waste belong 
to which bin, (Questions 2-4), 8.7% respondents (N=9/104) answered all three 
knowledge-based questions (Questions 2-4) correctly, while 15.4% of nurses 
(N=16/104) answered none of the questions correctly. Interestingly, the number of 
respondents who disposed of unused and excess medicines in the trash across all three 
knowledge based questions was: 8.7% (N=9/104) for p-listed drugs, 23.1% (N=24/104) 
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Figure 4: Frequency of Accuracy in Knowledge Based Questions 
The last portion explored how nurses were trained in pharmaceutical waste 
management (Question 5) and 63.5% of all nurses (N= 66/104) chose “Yale New Haven 
Hospital online training” and 23.1% of all nurses (N=24/104) chose “other nurses and 
colleagues” as a method for education. Moreover, 19.2% of participants (N=20/104) 
across all Intensive Care and Perioperative units said they never received training for 
the proper and safe disposal of medications. Additionally, 9.6% (N=10/104) nurses 
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offered qualitative input in the “other” category and stated that they learned about waste 
disposal through some of the following ways: in-service posters, signs near bins, and 
pharmacist on the floor. 
Attitudes Towards Pharmaceutical Waste Prevention (Question 6) 
The next part of the survey (Question 6) explores attitudes towards properly 
disposal for pharmaceutical waste. Respondents could check more than one box to 
indicate why they believe it is important to dispose of pharmaceutical waste correctly. 
95.2% of nurses (N=99/104) indicated that it is important to dispose of pharmaceutical 
waste correctly “to protect the environment,” while 1.9% of nurses (N=2/104) indicated 
that they “don't believe it’s important to segregate drug waste.” Moreover, 76.0% 
(N=79/104) of respondents also chose “to follow regulatory compliance” as a reason to 
properly dispose of waste, while only 50.0% (N=52/104) of respondents equate the 
significance of proper disposal to “saving money on drug disposal fees.” 
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Behaviors in Drug Disposal (Questions 7-8) 
 Questions 7-8 elicit reasons contributing to improper pharmaceutical waste 
disposal practices. 56.7% (N=59/104) of nurses ranked “lack knowledge” as the top 
contributor to improper pharmaceutical waste disposal practice by nursing staff, while 
“the lack of concern about adherence to proper waste segregation” was ranked as the 
least common reason. For Question 7, the distribution of “Years of experience” is 
described as followed: 49.0% of nurses (N=51/104) with “1-5 years of experience” 
believe that “lack of knowledge” is the top contributor to improper waste disposal. Only 
1.9% of nurses (N=2/104) %, who have “worked less than one year,” believed that the 
“lack of knowledge” is the top contributor to improper waste disposal. The results 
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Quality Improvement (Questions 9-10) 
One of the study’s main goals was to explore methods for waste prevention. 
Question 9 explored details about avoidable waste behaviors. The section begins with 
the statement: “Pharmaceutical waste refers to drugs that are opened/prepared, but not 
administered to a patient.  Sometimes drug waste is unavoidable, e.g., if a patient gets 
better and no longer needs infusions. Other times, drug waste is avoidable, meaning it 
could have been prevented. The following questions refer to AVOIDABLE waste.” The 
subsequent Question 9 asks about which situations create avoidable drug waste during 
nursing duties.  37.5% of nurses (N=39/104) indicated that the order for medication is 
less than the available package size as the top reason contributing to avoidable waste. 
33.6% of nurses (N=35/104) believe that errors in provider orders or changes in 
medication orders are the top cause of avoidable waste. 
 
In terms of preventing further waste at the nurse staff level, Question 10 asked 
participants to name ways conditions could be improved via an open text answer. 
Nurses stated that more pharmaceutical training, better labeling on bins, and better 
signage could be ways to improve compliance. The results were coded and calculated 
based on most commonly mentioned. 22.7% nurses (N=30/132) requested more 
training for safe disposal of medications, including during employee orientation and 
annual continuing education. Furthermore, 14.4(% of nurses (N=19/132) stated there 
should be disposal information on dispensed medication labels or Pyxis Machines 
(machines that dispense medications at the department level), and 19.7% of nurses 
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(N=26/132) mentioned there should be more signage.  22.7% of respondents 
(N=30/132) agreed that better training and education could be improved to increase 
proper waste segregation. Some nurses noted that they rarely go over waste 
segregation at orientation and the online training do not offer guidance.  
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Associations between Predictors and Outcomes 
Predictors such as gender, degree and years of experience were analyzed to find 
associations between outcomes of questions. Performed Chi-square tests for binary 
outcomes, ANOVA for continuous outcomes, and Kruskal-Wallis test for nonparametric 
outcomes. There were not any statistically significant outcomes for any of the questions 
by gender, degree, or years of experience. However, based on the results of a Kruskal-
Wallis test (a non-parametric version of ANOVA, since the dependent variable was 
ordinal), the only significant predictor was “years of experience” for the questions 
involving the perception of pharmaceutical waste and behaviors associated with 
improper waste segregation. An ordinal logistic regression model was generated using 
gender as the independent variable. However, these results were not statistically 
significant since the confidence interval included 1. Though multivariate analysis 
exploring the following predictors was explored, the non-statistically significant 
outcomes could be due to the limitations of sample size and limited distributions of 
predictors in nurses. The nature of the survey asked about knowledge, attitudes and 
behaviors and “years of experience” could be a significant predictor given that the 
length of experience could associate certain question outcomes. The multivariate 
analysis could be further explored \ if the sample size increases, to decrease variability 
across gender, years of experience, and degree. 
Chapter 5: Discussion 
In the United States, hospital waste management does not follow a standard 
system for pharmaceuticals. The United States Environmental Protection Agency and 
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Drug Enforcement Agency, along with other stakeholder agencies such as the Centers 
for Disease Control and Occupational Safety and Health Administration, play a 
significant role in the regulation of medical waste. However, pharmaceutical waste is 
typically regulated at a state level which can result in gaps in disposal management. 
Pharmaceutical waste management needs a more streamlined system. Given the 
complexity of pharmaceutical disposal management at the regulatory level, adherence 
to standards of proper practice at the occupational level can improve waste 
management in healthcare.  
The main goal of this study was to assess attitudes and knowledge gaps about 
pharmaceutical waste management and to explore methods to prevent waste at the 
source. This cross-sectional survey of ICU and OR nurses explored causes of excess 
pharmaceutical waste as well as disposal management at the nurse level.  This study 
showed that nearly 56% of participants feel that the lack of knowledge is the top reason 
that contributes to improper pharmaceutical waste disposal practices by nursing staff.  .  
The current study adds to what is already known about improper pharmaceutical 
waste disposal. One study concluded that though knowledgeable health care 
professionals such as nurses were trained in waste disposal methods, it did not always 
translate to safely practiced drug disposal which shows that this topic should be further 
explored (McCullagh et al., 2012). Like other studies, this current study demonstrated 
the importance of education, and interestingly this current study showed that there is a 
knowledge gap at Yale New Haven Hospital despite 63.5% of nurses (N=66/104) 
indicating that they learn about pharmaceutical waste from Yale New Haven Hospital 
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Training. This suggests that both the content and the frequency of the online training 
should be a priority for hospitals to increase pharmaceutical compliance.  
 Our study uncovered potential improvements in waste disposal at the nurse 
level. Hospital administration will benefit by building a culture that understands 
consequences on the health and the environment. Ultimately, if the administration can 
engage in fostering a clinically sustainable community, it could improve waste 
management, compliance, protect the public health and save on costs. It is clear from 
our study that nurses are engaged in behaviors that create avoidable waste and nurses 
may not be trained in proper disposal practices. However, nurses do think their 
behaviors play a role in the community given that many believe it is important to protect 
the environment and public health. Leaders in healthcare could benefit from this 
occupational engagement by building sustainability awareness into the hospital culture. 
Awareness can include administration improvements like educational, streamlined 
signage and bins throughout patient rooms and break rooms. Understanding perception 
and barriers of improper medication disposal would also factor in the likelihood that 
medical personnel would participate in proper disposal programs. 
The improved culture that understands consequences on the health and the 
environment should be cognizant of the barriers for improper medication disposal. Our 
survey uncovered that poor signage and the lack of bins for disposal are some issues 
that create barriers for proper disposal. It is also evident that due to the complexity of 
pharmaceutical waste regulations, there is a need for more consistent training. Nurses 
mentioned that orientation and online training lack explicit guidance on waste 
segregation. Interestingly, our study found that 16.7% of respondents mentioned that 
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they learned about waste management from other colleagues and nurses. One of the 
three methods for changing social health norms is by encouraging learning through peer 
behavior, making peer behavior visible, and creating peer expectations. A future action 
plan should include a collaborative approach involving all nurses and administration. 
The ultimate goal is to increase compliance amongst nurses and if hospitals can commit 
to building a sustainable culture, awareness that revolves around nurse norms and 
attitudes could create an impact. 
Strengths/Limitations 
The strength of this study is the exploration of nursing knowledge gaps about 
proper pharmaceutical disposal management, as well as prevention of pharmaceutical 
waste in hospital settings. The study also examines the implications for reducing waste 
generation at the source and explores disposal processes to identify opportunities to 
minimize environmental pollution. The results from the study can provide an 
understanding of pharmaceutical waste management systems which will aid 
constituencies to improve pharmaceutical disposal education and training. Additionally, 
the exploration of nurses’ knowledge, behavior, and attitudes can guide policies to be 
inclusive of barriers within pharmaceutical waste management. This study was a pilot, 
and our findings provide useful data on nurse perception of relevance to the practice of 
the competencies and behaviors at Yale New Haven Hospital. 
The study does display some limitations. The disadvantage to cross-sectional 
study design is that it includes the challenges associated with establishing a causal 
inference, and the findings represent on a single time and place (Pannucci, 2010). The 
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data represent a single institution. This may limit the possibility to generalize the results 
of this study to other institutions (Haneuse, 2016).  
Another limitation includes the survey distribution. The survey was distributed via 
email, flyer, and in-person recruitment. In-person recruitment started in the Medical 
Intensive Care Unit (MICU) with direct relationships with the staff. The methods for 
recruitment could result in selection bias because of the exclusion of the population not 
in the MICU. The survey relied on convenience sampling, and the survey may not have 
reached all nurses. Any non-responders may have different levels of attitude towards 
wasting pharmaceuticals. Their behavior may vary and they could be experiencing 
different challenges.  (Haneuse, 2016).  
 Since this is a pilot study, survey questions may have been ambiguous. 
(Pannucci, 2010). Survey questions were developed by a team of stakeholders at Yale 
New Haven Hospital (1 anesthesiologist, 1 physician, 1 RN, and 1 MPH candidate); 
therefore, results and analysis of the survey questions should be taken into 
consideration and may not be reflective of all knowledge, behavior, and practice 
amongst nurses. Also, with responses that require recall or estimation, responses may 
reflect recall bias of disposal practices. Another limitation might be that the study 
represents attitudes and behaviors reported by nurses.  
This survey represents nurses’ perceptions and opinions through qualitative 
approaches such as a “Likert Scale” or open text option; however, the exact amount of 
pharmaceutical disposal was not explored (Haneuse, 2016).Lastly, the sample size of 
the survey can add a limitation to the study. The sample size resulted in 104 
respondents who may not be representative. A follow-up study employing surveys with 
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a quantitative assessment of pharmaceutical waste utilizing the Pyxis machine (a 
machine that dispenses medications at a department level instead of a pharmacy) or 
other drug tracking machines could yield more productive results  
Conclusion and Future Recommendations 
The survey uncovered a considerable knowledge gap in nurses’ knowledge of 
pharmaceutical waste management and shed light on specific behaviors that lead to 
improper disposal practices.  Furthermore, the survey modeled methods for prevention 
of pharmaceutical waste and improved segregation among nursing staff. The main goal 
of this study was to explore waste management and utilize this evidence based 
research on understanding prevention at the nurse level. Methods for improvement 
included consistent and rigorous training at the departmental level and more 
accessibility to bins and signage. The training and education for nurses should be 
strengthened to include details about the importance of proper pharmaceutical disposal. 
In the longer term, waste prevention can prove to be beneficial cost and health wise for 
all communities of interest. Waste prevention allows for ongoing cost savings, increased 
resource efficiency, and improved environmental credentials. With more waste 
prevention and research happening at the occupational level, hospitals can take 
reasonable steps to prevent and reduce waste and demonstrate their environmental 
stewardship. 
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Appendix A: Survey Instrument 
A-D: Demographics 
Questions 1-10: Survey Questions 
 




B)Which Yale New Haven Hospital Campus do you currently work at? 
● York Street Campus 
● Saint Raphael Campus. 
 
C)Please choose which ICU you currently work at: 
● Cardiac Intensive Care Unit 
● Cardiothoracic Intensive Care Unit 
● Medical Intensive Care Unit 
● Neonatal Intensive Care Unit 
● Neurosurgical Intensive Care Unit 
● Pediatric Intensive Care Unit 
● Surgical Intensive Care Unit 
 
Question #1 :There are many types of pharmaceutical waste streams in the 
hospital setting. Waste segregation refers to placing a specific type of waste 
into the appropriate receptacle. 
I feel knowledgeable about which types of pharmaceutical waste goes in each 
bin: 
● Strongly Agree 
● Agree 
● Somewhat agree 
● Neither agree nor disagree 
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● Somewhat disagree 
● Disagree 
● Strongly disagree 
 
Question #2:Unused, P-listed medications should go into which of the 
following bins (CHOOSE ONE) 
● Blue Bin 
● Black Bin 
● Yellow Bin 
● Regular Trash Bin 
 
Question #3:A partially used antibiotic bag should be disposed into which of 
the following bins: (CHOOSE ONE) 
● Blue Bin 
● Black Bin 
● Yellow Bin 
● Regular Trash Bin 
 
Question #4:If you open a new syringe from its packaging, and accidentally 
drop it on the floor, which disposal bin should you use? (CHOOSE ONE) 
● Red Bin 
● Blue Bin 
● Recycling Bin 
● Regular Trash Bin 
 
Question #4:How did you learn about pharmaceutical waste segregation? 
(CHECK ALL THAT APPLY.) 
● Yale New Haven Hospital Online Training 
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● Other online training 
● Yale New Haven Hospital Environmental Services Officer 
● Other colleague/nurses 
● Nursing school 
● Other: __________ 
 
 
Question #5:I believe proper drug disposal is important because (CHECK ALL 
THAT APPLY)  
● to protect environmental health 
● to protect public health 
● to follow regulatory compliance 
● to save money on drug disposal fees 
● I don't believe it's important to segregate drug waste 
 
Question #6:Rank the following reasons, from MOST common (TOP) to 
LEAST common (BOTTOM), that contribute to improper pharmaceutical 
waste disposal practice by nursing staff. (DRAG AND DROP.) 
● Lack of knowledge about proper waste segregation 
● Lack of time to segregate waste 
● Lack of availability/convenient location of appropriate waste bins 
● Lack of concern about adherence to proper waste segregation 
● Other: __________ 
 
Question #7:Name one way conditions could be improved to increase proper 
waste segregation compliance among nursing staff  
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Question #8:Pharmaceutical waste refers to drugs that are opened/prepared, 
but not administered to a patient.  Sometimes drug waste is unavoidable, e.g., 
if a patient gets better and no longer needs infusions. Other times, drug waste 
is avoidable, meaning it could have been prevented. The following questions 
refer to AVOIDABLE waste. 
Question #9:What situation, ranked from MOST common (TOP) to LEAST 
common (BOTTOM), creates AVOIDABLE drug waste during nursing duties?  
(DRAG AND DROP.) 
● Error in provider order/Change in medication order 
● Order for medication is less than available package size 
● Expiration of an open drug (bag or syringe) 
● Time/production pressure leading to changing infusions prematurely 
● Lack of concern about wasteful practices 
 






● Choose not to respond 
E):How long have you worked as a nurse? 
● Less than 1 year 
● 1-5 years 
● 5-10 years 
● 10+ years 
F):What is your highest degree? 
● LPN 
● Certificate Prepared RN 
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Appendix B: Figures 
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Table 2: Pharmaceutical Waste Treatment and Disposal (Stericycle 2018 and EPA 2017): 
Table 2: Pharmaceutical Waste Treatment and Disposal (Stericycle 2018 and EPA 2017): 
 
Method Description Environmental/Health 
Impact 
Capital Costs Handling for Each Type of Drug 
Incineration The burning of waste at 
high temperatures (800-
900 °C) under oxygen-
starved conditions. 
   
Residual ash is land-filled, 
and can cause soil, air and 
water contamination.  
 
Water emissions occur 
when wet scrubbers are 
employed to remove 
particulates  
 
Burning of fossil fuels can 
result in air pollution (e.g., 
particulate matter 2.5) 
  
$2.2/kg to $4.4/kg 
   
   
   
  
    
   
Bulk and Trace Chemotherapy 
Pharmaceuticals 
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Autoclaving  
   
  
The steam heat of at 
least 121°C, combined 
with pressure are used 
to destabilize drugs and 
decontaminate 
associated sharps (e.g., 
needles). 
 
Heat transfer penetrates 
the waste load. 
Shredding will increase 
the exposure of waste to 
treatment, render sharps 
“unrecoverable,” as well 
as reduce waste volume.  
***Byproduct can be 
landfilled 
  
After autoclaving, waste 
goes to landfill. Waste can 
result in soil and land 
contamination through 
leaching of residual 
compounds. 
 
Contamination of water can 
occur from effluent.  
$36,000– $889,000  
   
   
Red Bag (Non-pathology) 
Red Sharps (Needle Bag) 
Microwave This process uses 
radiant energy to heat 
moisture within the 
waste and/or heat water 
that is added to the 
waste. Microwaving units 
kill infectious agents and 
drugs through heat and 
pressure, not as a result 
of exposure to the 
microwaves.  
   
After microwaving, waste 
goes to landfill. Waste can 
result in soil and land 
contamination through 





$600,000 Bulk and Trace Chemotherapy 
Pharmaceuticals 
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Chemical Treatment Chemicals are 
introduced into a 
sterilization chamber. 
With proper exposure 
conditions, waste is 
sterilized before going to 
landfill 
Sewage treatment 
processes can be 
negatively impacted by 
residual chemical 
compounds in waste water 
effluent.  
.      
With some chemical 
systems there is potential 
soil contamination in 
landfills.   
   
30,000-450,000 Bulk and Trace Chemotherapy 
Pharmaceuticals 
Landfill Landfills place waste 
directly into a land 
disposal site without 
prior treatment or 







3) Highly engineered 
sanitary landfill 
 
“One half of available 
carbon is converted to 
methane during 
degradation. Methane is 25 
times more destructive to 
the ozone layer than carbon 
dioxide.” 
 
Landfill must be monitored 
to prevent contamination of 
ground water. 
 
Must remove materials 
containing lead and 
mercury from landfills to 
decrease leachate in soil 
and water 
--------- Red Bag (Non-pathology) 
Red Sharps (Needle Bag) 
Municipal Trash 
 








Table 3 Matrix of All Studies Exploring Unavoidable and Avoidable Waste 
First Author, 






type Department Type of Facility 
Type of 
Pharmaceuticals 
Atcheson, 2016 New York, USA 
Observational 





Support OR Academic Hospital Anesthetics 
Almeida,2016 Sao Paulo, Brazil 
Observational 





Study OR + ICU University Hospital IV 
Abbassi, 2017 Tampa, Florida 
Observational 















Study ICU Teaching Hospital IV 
Chaudhary, 2012 India 
Observational 
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L'Hommedieu, 2010 New York, USA 
Observational 







Study ICU Children's Hospital IV 
Mankes,2012 USA 
Observational 
study 13 months 
International 
Anesthesia 
Society  Brief Report OR Academic Hospital Anesthetics 
More, 2015 India 
Observational 









Nava-Ocampo, 2004 Mexico 
Observational 



























Table 4 Subgroup Analysis: Intensive Care Units 
First Author, 
Publication Year 
Location Study Design 
Length of 
Study 








Abbassi, 2017 Tampa, Florida 
Observational 
Study 7 days Oral,IV 




phase 1 to phase 2 
($41 to $21 per 100 
patient days; p < 
.05) 
517 beds Total wasted CSPs decreased from 97 
doses wasted in phase 1 to 83 doses 
wasted in phase 2. These numbers 
represent 2.2% and 1.8%, respectively, of 





Study 3 months IV 
------------ 356  units Most discarded pharmacological classes 
were: 22.7% antimicrobials, 14.8% 
electrolytes, 14.6% analgesics/pain killers
  






Study 1 month IV 
-------------- 430 units 265 items of IV medication were collected 
during the study period. Antibiotics 
preparations (77%) were the most unused 
and wasted. Medication discontinuation 







Study 30 days 
IV a weekly savings of 
$8,197 ($426,244 
annually),  
500 beds Wasted i.v. doses decreased from 1,339 
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Study 12 months 
Anesthetics 185,250 543 cases Preventable waste was 
generated most frequently for 
ephedrine (59.5% of cases), 




Study 12 months 
Anesthetics The cost of wasted drugs 
for the study duration was 
46.57% $1604 of the total 
cost of drugs 
issued/loaded propofol 
was maximum being 
56.27% $928 
98 cases Maximal wastage was 
associated with adrenaline and 
lignocaine (100% and 93.63%, 
respectively). This is accounted 
for maximum wastage due to 
not being used after loading 
into a syringe. 
Mankes,2012  
Observational 
study 13 months 
Anesthetics ------------------ 8 
operating 
rooms 
Propofol was the most widely 
dispensed and wasted drug at 
the facility. and accounted for 
45% of the total drug waste by 
mL. Eliminating the 50 and 100 
mL bottles of propofol reduced 
the facility's propofol waste 
from 29.2 mL/day/bin to 2.8 
mL/day/bin. 
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More, 2015 India 
Observational 
study 3 months 
Anesthetics The cost of wasted drugs 
for study duration was 
29.82% $1027 of the total 
cost of drugs was loaded 
$3445. 
200 cases Thiopentone sodium was 
frequently used intravenous 
inducing anaesthetic agent in 
75% of patients.Amongst 
intravenous anaesthetic agents 
maximum wastage was 
associated with propofol of 
about 36.59% and in pre-
anaesthetics, wastage was 
maximum for atropine 79% 
followed by glycopyrrolate 
45.95%, pentazocine 45.95%.  
Nava-
Ocampo, 2004 Mexico 
Observational 
Study 1 year Anesthetics 
The median 
undocumented cost was 
US$92.4 (95% CI $17.2–
$216.6) per 100 requested 
units. 
100 units Two specific drugs, rocuronium 
and nalbuphine, were found to 
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Table 6 Demographics 
 N= 104 Value (%) 
Gender Female 81 77.9 
Male 17 16.3 
Other 2 1.9 
Choose no to respond 4 3.8 
Highest Degree BSN 66 63.5 
MSN 21 20.2 
APRN 11 2.9 
LPN 3 2.9 
CPN 3 10.6 
Years of experience Less than 1 year 4 3.8 
1-5 years 46 44.2 
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5-10 years 31 29.8 
More than 10 years 23 22.1 
Yale New Haven Campus York Street 75 72.1 
Saint Raphael 29 27.9 
ICU Nurse or Perioperative Nurse ICU 98 94.2 
Perioperative 6 5.7 
Type of Perioperative Nurse Intra-OP 6 100 
Type of ICU Nurse Medical ICU 87 83.7 
Cardiothoracic  ICU 12 11.5 
Pediatric ICU 3 2.9 
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Table 11: Pharmaceutical waste segregation training 
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Table 13: Knowledge-based Q1- P listed medications 
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Table 20: Most common medications 
 
